OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Comparisons between radiofrequency ablation and stereotactic body radiotherapy for liver malignancies: Meta-analyses and a systematic review
Jeongshim Lee, In‐Soo Shin, Won Sup Yoon, et al.
Radiotherapy and Oncology (2020) Vol. 145, pp. 63-70
Closed Access | Times Cited: 118

Showing 1-25 of 118 citing articles:

Locoregional therapies in the era of molecular and immune treatments for hepatocellular carcinoma
Josep M. Llovet, Thierry de Baère, Laura Kulik, et al.
Nature Reviews Gastroenterology & Hepatology (2021) Vol. 18, Iss. 5, pp. 293-313
Closed Access | Times Cited: 676

Management of Hepatocellular Carcinoma
Zachary J. Brown, Diamantis I. Tsilimigras, Samantha M. Ruff, et al.
JAMA Surgery (2023) Vol. 158, Iss. 4, pp. 410-410
Closed Access | Times Cited: 313

Hepatocellular Carcinoma
Previn Ganesan, Laura Kulik
Clinics in Liver Disease (2022) Vol. 27, Iss. 1, pp. 85-102
Closed Access | Times Cited: 267

External Beam Radiation Therapy for Primary Liver Cancers: An ASTRO Clinical Practice Guideline
Smith Apisarnthanarax, Aisling Barry, Minsong Cao, et al.
Practical Radiation Oncology (2021) Vol. 12, Iss. 1, pp. 28-51
Open Access | Times Cited: 138

The management of hepatocellular carcinoma. Current expert opinion and recommendations derived from the 24th ESMO/World Congress on Gastrointestinal Cancer, Barcelona, 2022
Michel Ducreux, Ghassan K. Abou‐Alfa, Tanios Bekaii‐Saab, et al.
ESMO Open (2023) Vol. 8, Iss. 3, pp. 101567-101567
Open Access | Times Cited: 81

Hepatocellular Carcinoma in 2021: An Exhaustive Update
Cyriac Abby Philips, S Rajesh, Dinu Chandran Nair, et al.
Cureus (2021)
Open Access | Times Cited: 100

Stereotactic body radiation therapy for hepatocellular carcinoma: From infancy to ongoing maturity
Shirley Lewis, Laura A. Dawson, Aisling Barry, et al.
JHEP Reports (2022) Vol. 4, Iss. 8, pp. 100498-100498
Open Access | Times Cited: 56

Advancements in the application of ablative therapy and its combination with immunotherapy in anti-cancer therapy
Luhong Wang, Yiyi Jiang, Chaoyue Sun, et al.
Biochimica et Biophysica Acta (BBA) - Reviews on Cancer (2025) Vol. 1880, Iss. 2, pp. 189285-189285
Closed Access | Times Cited: 1

ALKBH5-Modified HMGB1-STING Activation Contributes to Radiation Induced Liver Disease via Innate Immune Response
Genwen Chen, Qianqian Zhao, Baoying Yuan, et al.
International Journal of Radiation Oncology*Biology*Physics (2021) Vol. 111, Iss. 2, pp. 491-501
Closed Access | Times Cited: 42

Comparison of radiofrequency ablation and ablative external radiotherapy for the treatment of intrahepatic malignancies: A hybrid meta-analysis
Chai Hong Rim, Jung Sue Lee, Soo‐Yeon Kim, et al.
JHEP Reports (2022) Vol. 5, Iss. 1, pp. 100594-100594
Open Access | Times Cited: 32

The Current Role of Stereotactic Body Radiation Therapy (SBRT) in Hepatocellular Carcinoma (HCC)
Tomoki Kimura, Toshiki Fujiwara, Tsubasa Kameoka, et al.
Cancers (2022) Vol. 14, Iss. 18, pp. 4383-4383
Open Access | Times Cited: 30

Stereotactic Body Radiotherapy for Hepatocellular Carcinoma: A Brief Overview
Yukinori Matsuo
Current Oncology (2023) Vol. 30, Iss. 2, pp. 2493-2500
Open Access | Times Cited: 19

Image-guided Radiotherapy to Manage Respiratory Motion: Lung and Liver
Jennifer Dhont, Susan Harden, Lynette Chee, et al.
Clinical Oncology (2020) Vol. 32, Iss. 12, pp. 792-804
Open Access | Times Cited: 48

Stereotactic Radiotherapy for Hepatocellular Carcinoma, Radiosensitization Strategies and Radiation-Immunotherapy Combination
Luís A. Pérez-Romasanta, Elisabet González-Del Portillo, A. Rodríguez-Gutierrez, et al.
Cancers (2021) Vol. 13, Iss. 2, pp. 192-192
Open Access | Times Cited: 37

Hexokinase 2 confers radio-resistance in hepatocellular carcinoma by promoting autophagy-dependent degradation of AIMP2
Yilin Zheng, Yizhi Zhan, Yuqin Zhang, et al.
Cell Death and Disease (2023) Vol. 14, Iss. 8
Open Access | Times Cited: 14

Olaparib enhances radiation-induced systemic anti-tumor effects via activating STING-chemokine signaling in hepatocellular carcinoma
Genwen Chen, Danxue Zheng, Yimin Zhou, et al.
Cancer Letters (2023) Vol. 582, pp. 216507-216507
Closed Access | Times Cited: 14

Exploring the Evolving Landscape of Stereotactic Body Radiation Therapy in Hepatocellular Carcinoma
Deepti Sharma, Divya Khosla, Babu Lal Meena, et al.
Journal of Clinical and Experimental Hepatology (2024) Vol. 15, Iss. 1, pp. 102386-102386
Closed Access | Times Cited: 4

Comparison of stereotactic body radiotherapy and radiofrequency ablation for hepatocellular carcinoma: Systematic review and meta‐analysis of propensity score studies
Takahisa Eriguchi, Atsuya Takeda, Yudai Tateishi, et al.
Hepatology Research (2021) Vol. 51, Iss. 7, pp. 813-822
Closed Access | Times Cited: 23

Radiofrequency ablation of hepatocellular carcinoma: Current status, challenges, and prospects
Hongye Wang, Zhaorong Wu, Dan Cui, et al.
Liver Research (2023) Vol. 7, Iss. 2, pp. 108-115
Open Access | Times Cited: 8

Updates on the Diagnosis and Management of Hepatocellular Carcinoma
Aimun Raees, Muhammad Kamran, Hasan Özkan, et al.
Euroasian Journal of Hepato-Gastroenterology (2021) Vol. 11, Iss. 1, pp. 32-40
Open Access | Times Cited: 18

The role of hyperthermia in the treatment of tumor
Weiwei Zhu, Siwei Pan, Jiaqing Zhang, et al.
Critical Reviews in Oncology/Hematology (2024), pp. 104541-104541
Closed Access | Times Cited: 2

Page 1 - Next Page

Scroll to top